Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 1 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Prognosys Biosciences Inc. is managing 4 pending office actions in the Biotechnology & Pharmaceuticals sector. These actions are being reviewed by 3 distinct examiners, showing some overlap in the personnel assigned to the portfolio. All of these matters are located within 1 distinct art unit, indicating a highly specialized technical focus for the company's current patent activities. This concentration within the art unit may allow for a more unified prosecution strategy, as the examiners likely share similar technical backgrounds and internal group guidelines.
CROW, ROBERT THOMAS is the busiest examiner for this portfolio, as he is responsible for 2 pending office actions. This concentration means that 2 of the company's active prosecution matters are subject to the review of a single individual. Practitioners should note that the consistency of the art unit may allow for more uniform arguments across the 4 pending actions. Because CROW, ROBERT THOMAS handles a portion of the actions, his specific feedback will be particularly influential in determining the overall success rate of the company's current biotechnology filings.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CROW, ROBERT THOMAS | 2 | 41.7% | +32.7% |
| OLSON, ALEXANDRA NADINE | 1 | 100.0% | +0.0% |
| PARISI, JESSICA DANIELLE | 1 | 75.8% | +32.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19264527 | SPATIALLY ENCODED BIOLOGICAL ASSAYS | CROW, ROBERT THOMAS | — |
| 19264491 | SPATIALLY ENCODED BIOLOGICAL ASSAYS | CROW, ROBERT THOMAS | — |
| 19021456 | METHODS AND SYSTEMS FOR DETERMINING SPATIAL PATTERNS OF BIOLOGICAL TARGETS IN A SAMPLE | OLSON, ALEXANDRA NADINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19264527 | SPATIALLY ENCODED BIOLOGICAL ASSAYS | CROW, ROBERT THOMAS | — |
| 19264491 | SPATIALLY ENCODED BIOLOGICAL ASSAYS | CROW, ROBERT THOMAS | — |
| 18414337 | METHODS FOR DETECTING PEPTIDE/MHC/TCR BINDING | PARISI, JESSICA DANIELLE | — |
| Art Unit | Apps |
|---|---|
| 1683 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19264527 | SPATIALLY ENCODED BIOLOGICAL ASSAYS | CROW, ROBERT THOMAS | 1683 | §103§112 | Final Rejection | — | Pending | Jul 09, 2025 |
| 19264491 | SPATIALLY ENCODED BIOLOGICAL ASSAYS | CROW, ROBERT THOMAS | 1683 | §103§112 | Final Rejection | — | Pending | Jul 09, 2025 |
| 19021456 | METHODS AND SYSTEMS FOR DETERMINING SPATIAL PATTERNS OF BIOLOGICAL TARGETS IN A SAMPLE | OLSON, ALEXANDRA NADINE | — | §101§112Other | Non-Final OA | — | Pending | Jan 15, 2025 |
| 18414337 | METHODS FOR DETECTING PEPTIDE/MHC/TCR BINDING | PARISI, JESSICA DANIELLE | — | §102DP | Non-Final OA | — | Pending | Jan 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial